Hormonal control of growth factor receptor expression

被引：7
作者：
DeBortoli, M
Maggiora, P
Capello, D
Antoniotti, S
Saviozzi, S
Sapei, ML
Dati, C
机构：
来源：
BASIS FOR CANCER MANAGEMENT | 1996年 / 784卷
关键词：
D O I：
10.1111/j.1749-6632.1996.tb16248.x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：336 / 348
页数：13
相关论文
共 46 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]   TAMOXIFEN UP-REGULATES C-ERBB-2 EXPRESSION IN ESTROGEN-RESPONSIVE BREAST-CANCER CELLS-INVITRO [J].
ANTONIOTTI, S ;
MAGGIORA, P ;
DATI, C ;
DEBORTOLI, M .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :318-321
[3]   ESTROGEN AND EPIDERMAL GROWTH-FACTOR DOWN-REGULATE ERBB-2 ONCOGENE PROTEIN EXPRESSION IN BREAST-CANCER CELLS BY DIFFERENT MECHANISMS [J].
ANTONIOTTI, S ;
TAVERNA, D ;
MAGGIORA, P ;
SAPEI, ML ;
HYNES, NE ;
DEBORTOLI, M .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1095-1101
[4]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[5]  
BARNES DM, 1993, J CELL BIOCHEM, P132
[6]   POTENTIAL VALUE OF HORMONE RECEPTOR ASSAY IN CARCINOMA INSITU OF BREAST [J].
BARNES, R ;
MASOOD, S .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (05) :533-537
[7]   ERBB2 AMPLIFICATION IS ASSOCIATED WITH TAMOXIFEN RESISTANCE IN STEROID-RECEPTOR POSITIVE BREAST-CANCER [J].
BORG, A ;
BALDETORP, B ;
FERNO, M ;
KILLANDER, D ;
OLSSON, H ;
RYDEN, S ;
SIGURDSSON, H .
CANCER LETTERS, 1994, 81 (02) :137-144
[8]   THE DEVELOPMENTALLY-REGULATED TRANSCRIPTION FACTOR AP-2 IS INVOLVED IN C-ERBB-2 OVEREXPRESSION IN HUMAN MAMMARY-CARCINOMA [J].
BOSHER, JM ;
WILLIAMS, T ;
HURST, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :744-747
[9]  
CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303
[10]   A NEU ACQUAINTANCE FOR ERBB3 AND ERBB4 - A ROLE FOR RECEPTOR HETERODIMERIZATION IN GROWTH SIGNALING [J].
CARRAWAY, KL ;
CANTLEY, LC .
CELL, 1994, 78 (01) :5-8
12345